Clinical Trials on Primary Cutaneous DLBCL, Leg Type
Total 8986 results
-
National Cancer Institute (NCI)RecruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7United States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Cutaneous MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Metastatic Malignant Neoplasm in the Brain | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Metastatic Uveal Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous... and other conditionsUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Innovent Biologics (USA), Inc.WithdrawnMetastatic Cutaneous Melanoma | Unresectable Cutaneous MelanomaUnited States, Germany, France, Australia, Spain, Switzerland, United Kingdom
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedRelapsed Cutaneous T Cell LymphomChina
-
Kyowa Kirin, Inc.RecruitingCutaneous T Cell Lymphoma | ATLL | Leukemia/LymphomaUnited States
-
Ruijin HospitalRecruitingPrimary Mediastinal Large B Cell Lymphoma | EBV-Positive DLBCL, NosChina
-
Centre Hospitalier de CayenneNot yet recruitingTreatment Adherence | Primary Health Care | Cutaneous Leishmaniases | Drug Evaluation
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
University Health Network, TorontoNot yet recruitingDiffuse Large B Cell Lymphoma (DLBCL)Canada
-
Hoffmann-La RocheRecruitingDiffuse Large B-Cell Lymphoma (DLBCL)United States
-
Elizabeth Buchbinder, MDGenentech, Inc.RecruitingStage IV Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Unresectable Stage III Cutaneous Melanoma | Unresectable Stage IV Cutaneous MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Unresectable MelanomaUnited States
-
Richard WuIovance Biotherapeutics, Inc.Active, not recruitingLocally Advanced Melanoma | Stage IV Melanoma | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8United States
-
Azienda Socio Sanitaria Territoriale degli Spedali...RecruitingAcute Lymphoblastic Leukemia (ALL) | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma (DLBCL)Italy
-
National Cancer Institute (NCI)CompletedLymphoma | Cutaneous | T-CellUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Advanced Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
National Cancer Institute (NCI)TerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage II Cutaneous T-cell Non-Hodgkin LymphomaUnited States
-
Jiangsu Simcere Biologics Co., LtdRecruitingAdvanced Solid Tumor | Cutaneous T Cell LymphomaChina
-
Joseph ButterfieldTerminatedCutaneous MastocytosesUnited States
-
CHU de ReimsUnknownIndolent Cutaneous B Cell LymphomasFrance
-
National Cancer Institute (NCI)CompletedRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 | Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7United States
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Metastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Stanford UniversityTerminatedCutaneous T-cell Lymphoma | Cutaneous LymphomaUnited States
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B Cell Lymphoma (DLBCL) | Elderly Patients (>65 Years)Italy
-
Peking Union Medical College HospitalRecruitingCutaneous T-cell LymphomaChina
-
Peking Union Medical College HospitalPeking University Third Hospital; Dongzhimen Hospital, Beijing; Beijing Longfu...RecruitingCutaneous T-cell LymphomaChina
-
Northwestern UniversityRecruitingCutaneous T Cell LymphomaUnited States
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
Cyclacel Pharmaceuticals, Inc.TerminatedA Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaCutaneous T-cell Lymphoma (CTCL)United States
-
Galderma R&DCompletedCutaneous T Cell LymphomaUnited States, France, Germany
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCutaneous T Cell LymphomaUnited States
-
NYU Langone HealthTerminatedCutaneous T Cell LymphomaUnited States
-
Far Eastern Memorial HospitalUnknownCutaneous T-cell LymphomaTaiwan
-
Morphogenesis, Inc.H. Lee Moffitt Cancer Center and Research InstituteCompletedCutaneous Melanoma, Stage III | Cutaneous Melanoma, Stage IVUnited States
-
Northwestern UniversityNot yet recruitingCutaneous T Cell LymphomaUnited States
-
Universitätsmedizin MannheimKlinikum Ludwigshafen; Wuerzburg University Hospital; KKS Netzwerk; Klinikum Minden and other collaboratorsCompletedCutaneous T Cell LymphomaGermany
-
Codiak BioSciencesTerminatedCutaneous T-cell Lymphoma (CTCL)United Kingdom
-
Weiyun AiCelgene CorporationCompletedLymphoma | T-Cell Lymphoma | Cutaneous LymphomaUnited States
-
NYU Langone HealthLudwig Institute for Cancer ResearchTerminatedCutaneous T-cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Solid Neoplasm | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma... and other conditionsUnited States
-
2seventy bioRecruitingDiffuse Large B Cell Lymphoma (DLBCL)United States
-
NanOlogy, LLCUS Biotest, Inc.Completed
-
Masonic Cancer Center, University of MinnesotaRecruitingDiffuse Large B Cell Lymphoma | DLBCL | High-grade B-cell Lymphoma | DLBCL Arising From Follicular LymphomaUnited States
-
M.D. Anderson Cancer CenterCompletedPathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8United States